论文部分内容阅读
目的:了解快速性心律失常患者在急诊治疗中应用胺碘酮的临床效果。方法:纳入本院2013-2016年期间急诊收治确诊为快速性心律失常患者80例为此次研究数据主要来源,其中40例患者应用常规快速性心律失常对症治疗方案并设为对照组,另40例在对照组治疗基础上联合胺碘酮患者设为观察组。比较两种快速性心律失常治疗方案对患者病情的改善效果以及不良反应。结果:经相关快速性心律失常疗效标准评价,对照组有10例患者判定无效,观察组有3例患者判定无效,总有效率分别为75.0%、92.5%。组间数据统计学软件处理,提示有意义,P<0.05;观察组随访期间有1例出现不良反应,对照组有8例出现不良反应,组间数据统计学软件处理,提示有意义,P<0.05。结论:快速性心律失常患者在制定治疗方案过程中可在对症干预基础上与胺碘酮药物相联合,对提高临床治疗效果有重要意义,缓解患者临床症状并保障治疗安全性,值得临床推广。
Objective: To investigate the clinical effect of amiodarone in emergency treatment of tachyarrhythmia patients. Methods: Eighty patients diagnosed with tachyarrhythmia admitted to our hospital during 2013-2016 were the main source of the data. Forty patients underwent routine symptomatic treatment of tachyarrhythmia, and the other 40 Cases in the control group based on the treatment of amiodarone combined with the observation group. To compare two kinds of tachyarrhythmia treatment program to improve the patient’s condition and adverse reactions. Results: According to the evaluation criteria of tachyarrhythmia, 10 patients in the control group were invalid, and 3 patients in the observation group were invalid. The total effective rates were 75.0% and 92.5% respectively. There was an adverse reaction in 1 case in the observation group during the follow-up period, and 8 cases in the control group showed adverse reactions. Data processing between groups was statistically significant, suggesting a significant difference (P <0.05) 0.05. Conclusions: Tachyarrhythmia patients can be combined with amiodarone drugs on the basis of symptomatic intervention in the process of making treatment plan, which is of great significance to improve the clinical treatment effect, relieve the clinical symptoms and ensure the safety of treatment, and worthy of clinical promotion.